Surginus
PrivateLast Round
Pre Seed
Feb 1, 2022
Total Funding Raised
$1.25M
Company Overview
Surginus is a surgical devices company that develops and manufactures a foldable skin closure device as a non-invasive alternative to traditional sutures and staples.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Surginus Comps
Public and private peers based on sector, stage, and business model.
Surginus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Feb 1, 2022 | ||||
| Seed | Dec 1, 2020 |
Surginus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CNT Tech | Pre Seed |
| Banks Foundation for Young Entrepreneurs D.Camp | Seed |
| IBK Changgong | Seed |
| Mirae Science and Technology Holdings | Seed |
| We Ventures | Pre Seed |
| Korea Credit Guarantee Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2022
$1.25M round led by We Ventures and CNT Tech.
- Dec 1, 2020
Raised Seed round with Mirae Science and Technology Holdings and D.Camp.
Surginus Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Surginus's valuation, stock price, and market status.
